High-density seeding of myocyte cells for cardiac tissue engineering.

Tissue engineering of 1- to 5-mm-thick, functional constructs based on cells that cannot tolerate hypoxia for prolonged time periods (e.g., cardiac myocytes) critically depends on our ability to seed the cells at a high and spatially uniform initial density and to maintain their viability and function. We hypothesized that rapid gel-cell inoculation in conjunction with direct medium perfusion through the seeded scaffold would increase the rate, yield, viability, and uniformity of cell seeding. Two cell types were studied: neonatal rat cardiomyocytes for feasibility studies of seeding and cultivation with direct medium perfusion, and C2C12 cells (a murine myoblast cell line) for detailed seeding studies. Cells were seeded at densities corresponding to those normally present in the adult rat heart ([0.5-1] x 10(8) cells/cm(3)), into collagen sponges (13 mm x 3 mm discs), using Matrigel as a vehicle for rapid cell delivery. Scaffolds inoculated with cell-gel suspension were seeded either in perfused cartridges with alternating medium flow or in orbitally mixed Petri dishes. The effects of seeding time (1.5 or 4.5 h), initial cell number (6 or 12 million cells per scaffold), and seeding set-up (medium perfusion at 0.5 and 1.5 mL/min; orbitally mixed dishes) were investigated using a randomized three-factor factorial experimental design with two or three levels and three replicates. The seeding cell yield was consistently high (over 80%), and it appeared to be determined by the rapid gel inoculation. The decrease in cell viability was markedly lower for perfused cartridges than for orbitally mixed dishes (e.g., 8.8 +/- 0.8% and 56.3 +/- 4%, respectively, for 12 million cells at 4.5 h post-seeding). Spatially uniform cell distributions were observed in perfused constructs, whereas cells were mainly located within a thin (100-200 microm) surface layer in dish seeded constructs. Over 7 days of cultivation, medium perfusion maintained the viability and differentiated function of cardiac myocytes, and the constructs contracted synchronously in response to electrical stimulation. Direct perfusion can thus enable seeding of hypoxia-sensitive cells at physiologically high and spatially uniform initial densities and maintain cell viability and function.

[1]  R. Weisel,et al.  Survival and function of bioengineered cardiac grafts. , 1999, Circulation.

[2]  Thomas Eschenhagen,et al.  Three‐dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  Thomas Eschenhagen,et al.  Three-dimensional engineered heart tissue from neonatal rat cardiac myocytesThis work is part of the doctoral thesis of W. H. Z. at the University of Hamburg. , 2000 .

[4]  G. Koh,et al.  Differentiation and long-term survival of C2C12 myoblast grafts in heart. , 1993, The Journal of clinical investigation.

[5]  D J Mooney,et al.  Dynamic seeding and in vitro culture of hepatocytes in a flow perfusion system. , 2000, Tissue engineering.

[6]  P. Menasché,et al.  Can grafted cardiomyocytes colonize peri-infarct myocardial areas? , 1996, Circulation.

[7]  F J Schoen,et al.  Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. , 1999, Biotechnology and bioengineering.

[8]  S R Gonda,et al.  Cardiac organogenesis in vitro: reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells. , 1999, Tissue engineering.

[9]  M. Peel,et al.  Control of attachment, morphology, and proliferation of skeletal myoblasts on silanized glass. , 1999, Journal of biomedical materials research.

[10]  P. Arthur,et al.  Protein synthesis during oxygen conformance and severe hypoxia in the mouse muscle cell line C2C12. , 2000, Biochimica et biophysica acta.

[11]  Gordana Vunjak-Novakovic,et al.  Perfusion improves tissue architecture of engineered cardiac muscle. , 2002, Tissue engineering.

[12]  R. Hruban,et al.  Arterial delivery of genetically labelled skeletal myoblasts to the murine heart: long-term survival and phenotypic modification of implanted myoblasts. , 1996, Cell transplantation.

[13]  D L Eckberg,et al.  Mathematical treatment of autonomic oscillations. , 1999, Circulation.

[14]  P. Schwartz,et al.  Determinants of cardiomyocyte development in long-term primary culture. , 1988, Journal of molecular and cellular cardiology.

[15]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[16]  R Langer,et al.  Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. , 2001, American journal of physiology. Heart and circulatory physiology.

[17]  R J Cohen,et al.  Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. , 1999, American journal of physiology. Heart and circulatory physiology.

[18]  R. Weisel,et al.  Construction of a bioengineered cardiac graft. , 2000, The Journal of thoracic and cardiovascular surgery.

[19]  C. Murry,et al.  Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing? , 2000, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[20]  G. Koh,et al.  Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. , 1994, Science.

[21]  W. Zimmermann,et al.  Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. , 2000, Biotechnology and bioengineering.

[22]  T. Borg,et al.  Recognition of extracellular matrix components by neonatal and adult cardiac myocytes. , 1984, Developmental biology.

[23]  Gordana Vunjak-Novakovic,et al.  Effects of oxygen on engineered cardiac muscle. , 2002, Biotechnology and bioengineering.

[24]  Harold R. Lindman Analysis of Variance in Experimental Design , 1991 .

[25]  L. Kedes,et al.  Can a few good cells now mend a broken heart? , 1993, The Journal of clinical investigation.

[26]  R Langer,et al.  A biodegradable composite scaffold for cell transplantation , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[27]  Thomas Eschenhagen,et al.  Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  C. Mandarim-de-Lacerda,et al.  Numerical Density of Cardiomyocytes in Chronic Nitric Oxide Synthesis Inhibition , 2000, Pathobiology.

[29]  T. Borg,et al.  Extracellular matrix components influence the survival of adult cardiac myocytes in vitro. , 1985, Experimental cell research.

[30]  M. Soonpaa,et al.  Survey of studies examining mammalian cardiomyocyte DNA synthesis. , 1998, Circulation research.

[31]  J. Leor,et al.  Bioengineered Cardiac Grafts: A New Approach to Repair the Infarcted Myocardium? , 2000, Circulation.